secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2025-10-09T23:59:59+00:00
Accession:  0001213900-25-097564
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay expands SanyoSeiko partnership for Symphony platform commercialization
------------------------------------------------------------------------------

- SanyoSeiko will serve as contract manufacturing organization for analyzers, cartridges, and components.
- SanyoSeiko to oversee fulfillment, kit assembly, labeling, packaging, shipping, and quality control.
- Partnership includes manufacturing redevelopment, raw material sourcing, vendor compliance, and regulatory support.
- Bluejay's Symphony platform is a near-patient testing system for biomarkers like IL-6 in sepsis management.
- No financial terms disclosed; Symphony not yet FDA cleared.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390025097564/0001213900-25-097564-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390025097564/ea0260646-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-097564

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer